Sign in Subscribe
Nanotechnology

Novel Biodegradable Amphiphilic Copolymer with Potential as Tumor Targeting Drug Carrier

Strategic Insights

— 1 min read

Scientists in Jiamusi, People's Republic of China, have developed a novel biodegradable amphiphilic copolymer based on dextran and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE). The copolymer self-assembles into polymeric micelles in an aqueous solution, which can be used as a tumor targeting drug carrier. Researchers incorporated doxorubicin (DOX) into the polymeric nanoparticles, demonstrating a greater antitumor effect than free DOX on HeLa cells. This breakthrough has significant potential for the development of novel drug delivery systems.

Key Takeaways:

  • A novel biodegradable amphiphilic copolymer was successfully prepared by scientists in Jiamusi, People's Republic of China, based on dextran and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE).
  • The copolymer self-assembles into polymeric micelles in an aqueous solution, exhibiting amphiphilic properties.
  • Fluorescence spectroscopy, dynamic light scattering (DLS), and transmission electron microscope (TEM) confirmed the formation of copolymeric micelles.
  • Doxorubicin (DOX) was incorporated into the polymeric nanoparticles, demonstrating a greater antitumor effect than free DOX on HeLa cells.
  • The dextran/DPPE nanoparticles have great potential as a tumor targeting drug carrier, suggesting a new approach for cancer treatment.
  • H.X. Gao and colleagues from the Affiliated Hospital in Jiamusi University reported the study in the Journal of Applied Polymer Science.
  • The research provides a foundation for further investigation into the development of novel biodegradable amphiphilic copolymers as drug delivery systems.

Statistics:

  • 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) is used as a component in the biodegradable amphiphilic copolymer.
  • Doxorubicin (DOX) was incorporated into polymeric nanoparticles at an unspecified concentration.
  • The research demonstrated a greater antitumor effect of DOX-loaded nanoparticles compared to free DOX on HeLa cells.

Sources:

  • Gao et al. (2011). Novel Amphiphilic Dextran Copolymers Nanoparticles for Delivery of Doxorubicin. Journal of Applied Polymer Science, 2011;120(4):2448-2458.
  • Biotech Week editors (2011). Novel Biodegradable Amphiphilic Copolymer with Potential as Tumor Targeting Drug Carrier. Biotech Week via NewsRx.com.

Read more